logo

Eva Pharma launches its first production of "poultry medicines" before the season of «winter diseases»

28 Sep, 2022
https://evawebsite.blob.core.windows.net/media/assets/3_3c1292f4a3.png

Eva Pharma launches its first production of "poultry medicines" before the season of «winter diseases»

28 Sep, 2022

Cairo,September 28,2022- Eva Pharma, a leading pharmaceutical company, launched its first production of veterinary drugs targeted at the poultry wealth sector, in a major event attended by a selection of professors of veterinary faculties, veterinarians and supervisors, which included discussions on the various topics suffered by the «sector», as well as introducing them to new veterinary preparations and their importance in the treatment of various diseases that may affect poultry. 

From time to time, the poultry industry suffers from various diseases or epidemics that may cause huge losses, leading to higher poultry prices at times, and other losses to breeders, affecting this important industry as a whole. 

Dr. Ahmed Waked, Director General of Eva Pharma's Animal Health Department, said that the company launched antibiotics and medicines for livestock and large animals months ago, this time launching drugs for the poultry sector, which are important antibiotics, antidotes for Coccidiosis, and a host of other important preparations. 

 

The Director General of the Animal Health Department at «Eva Pharma» added at the launch ceremony of the new drugs, that the company is interested in providing treatments of international quality, at an affordable price to veterinarians, breeders and supervisors, which reflects on livestock and poultry positively, and consequently on human health and the economy. 

Dr. Ahmed Waked stressed that Eva Pharma will continue in the coming period to pay attention to medicines and treatments for livestock, to face the shortage suffered by some veterinary products. 

 He said that other products will be launched in the coming period, including a range of veterinary vaccines that will be available in the market during 2023, explaining that the company aims to expand the provision of these treatments in the countries of the Middle East and Africa at a later stage, after providing the needs of the Egyptian market from them. 

 

Dr. Mostafa Bastamy, professor and consultant of poultry diseases and former dean of the Faculty of Veterinary Medicine at Cairo University, praised the direction of Eva Pharma for the manufacture of veterinary drugs and preparations, adding that he used it as an experiment after its recent launch, and it came with great results. 

 

Dr. Magdy El-Kady, Professor of Poultry Diseases and Chairman of the Board of Directors of the Egyptian Poultry Veterinary Association, said that these drugs are offered at a distinct time, as the winter season is a season accompanied by diseases in the field of poultry industry, and sometimes causes major problems, but the conditions are less severe in the rest of the year. 

During his participation in the conference, the Chairman of the Board of Directors of the Egyptian Poultry Veterinary Association added that the accession of «Eva», a long-standing company, represents a shift in the technology of the veterinary pharmaceutical industry in Egypt, and that he used the first drugs that it put forward, and came with outstanding results. 

eva logo

We empower the fight for health and well being as a human right.

Subscribe for our latest news and updates

Quick Links

Follow Us

Facebook
Linkedin
youtube yellow
instagram
twitterx
© 2022 Eva Pharma All Rights Reserved - شركة ايفا فارما للادوية و المستلزمات الطبية